TPM1TPM4

TPM1TPM4 refers to a specific gene fusion product found in certain cancers. This fusion occurs when parts of two distinct genes, TPM1 (Tropomyosin 1) and TPM4 (Tropomyosin 4), are joined together due to a chromosomal rearrangement. Tropomyosins are a family of proteins involved in the regulation of muscle contraction and other cellular processes. The TPM1TPM4 fusion gene can result in the production of an abnormal tropomyosin protein that may contribute to tumor development and progression. The specific clinical significance and therapeutic implications of TPM1TPM4 fusions are areas of ongoing research. Detection of this gene fusion is typically performed through molecular diagnostic techniques such as polymerase chain reaction (PCR) or next-generation sequencing. Its presence can be a biomarker for certain types of cancer, although it is not as commonly identified as some other gene fusions. Understanding the role of TPM1TPM4 fusions helps in the classification of tumors and may offer insights into potential targeted treatment strategies in the future.